En español
NIDA

NIDA Notes Articles: Medication Development

NIDA Notes Category Graphic

Testing a Prospective Medication To Help People Avoid Relapse

March 2016
This NIDA Notes animation depicts a basic experiment that researchers use to test whether a prospective new medication can prevent relapse to drug addiction.

NIDA Notes Category Graphic

Stress-Induced Enzyme Compounds Methamphetamine Neurotoxicity

January 2014
Ketoprofen, an anti-inflammatory agent commonly prescribed to treat arthritis, reduces neuronal damage in rats that have been exposed to chronic stress and methamphetamine. If this finding of a recent NIDA-supported study extrapolates to humans, anti-inflammatory medications may gain a place in the treatment of methamphetamine addiction.

NIDA Notes Category Graphic

Quinine as a Tracer for Medication Adherence

September 2016
Patients who don’t take their medications as prescribed often put themselves at risk for problems including misdiagnoses, complications, and death. A study suggests that adding low doses of quinine to patients’ medications could provide an inexpensive, reliable, and safe method of monitoring whether patients are taking their medications as directed.

NIDA Notes Category Graphic

Promising Advances in the Search for Safer Opioids

February 2017
New studies show that two novel compounds powerfully suppressed animals’ pain responses, while producing little or none of the respiratory depression and liability for misuse and abuse associated with morphine and other typical opioids.

NIDA Notes Category Graphic

Novel Compound Alleviates Hard-to-Treat Pain in Mice

June 2018
A novel compound called GAT211 alleviates inflammatory and neuropathic pain in mice without producing tolerance or signs of abuse liability.

NIDA Notes Category Graphic

Narrative of Discovery: The Quest for a Medication To Treat Methamphetamine Addiction, Part 3

May 2018
Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first ever medication to treat methamphetamine addiction.

NIDA Notes Category Graphic

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction, Part 2

April 2016
When lobeline turned out not to be the answer, it became a starting point. Dr. Linda Dwoskin and her team set out to transform the molecule into something more effective and with fewer side effects.

NIDA Notes Category Graphic

Narrative of Discovery: In Search of a Medication To Treat Methamphetamine Addiction

January 2015
This is the first in a series of NIDA Notes articles that will follow a team of researchers seeking a medication for methamphetamine addiction. This installment describes the early promise of the compound lobeline and the new directions the team discovered in studying it.

NIDA Notes Category Graphic

Microneedle Milestone: One Week of Transdermal Drug Delivery

March 2014
Microneedles are an innovative technique for delivering medications through the skin, a route that could particularly benefit patients receiving naltrexone therapy for opioid and alcohol dependence. Researchers have found a way to use the transdermal technique to deliver a single treatment of naltrexone that lasts for 7 days.

NIDA Notes Category Graphic

In Animals, Opioid Combination Shows Promise for Safer Pain Relief

June 2018
In rats, the combination treatment of oxycodone/nalfurafine had lower levels of abuse liability and produced less respiratory depression than oxycodone alone.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics